What should you do if a patient signs a general authorization for disclosure of medical records and you notice they were treated in a chemical dependency program?

In the context of handling medical records, especially those related to sensitive information such as treatment in a chemical dependency program, it is crucial to recognize the specific legal protections that apply. A general authorization for disclosure does not automatically cover sensitive information that is protected under laws like 42 CFR Part 2, which governs the confidentiality of substance use disorder patient records.

When a patient signs a general authorization but the records contain information from a chemical dependency program, special authorization is typically required before that information can be disclosed. By sending a letter requesting special authorization, you are ensuring compliance with legal standards that protect the patient's privacy. This step demonstrates an understanding of the need for additional consent when handling sensitive medical information, thereby safeguarding both the patient's rights and your organization from potential legal repercussions.

In scenarios involving chemical dependency treatment, it is essential to approach the situation with caution, emphasizing the importance of specific consent for such records. This process not only protects the patient's confidentiality but also maintains the integrity of the health information release process, which is central to the responsibilities of a Certified Release of Information Specialist.